MC3-LNP

N/A

Report date: 2022/02/08 10:39:44
NME

Base Information

Drug NameMC3-LNP
Drug Alias NamereLNP
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionDNA-directed DNA polymerase inhibitorsRNA interference
TargetsDNA-directed DNA polymerase
Therapy Area/IndicationsInfluenza A virus infectionsInflammationAutoimmune Diseases +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlnylam Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlnylam Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsInfluenza A virus infectionsInflammationAutoimmune Diseases +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A